This series will present new cases to ensure that the responsible healthcare personnel provide the patient with NCCN guideline appropriate care. Imaging and pathology are reviewed for each tumor to determine typical and atypical features that might influence treatment.

OBJECTIVES: Upon completion of this activity, the participant should be able to:  Evaluate patients with renal/prostate cancers based on a centralized review of pathology and radiology, (2) Identify appropriate NCCN guideline-based care for patients with primary renal/prostate cancer, as well as metastatic disease.

FACULTY DISCLOSURE: Scott Webster, MD has a relevant financial affiliation. He has received an honorarium as a speaker for Astellas.  All relevant financial relationships have been resolved.

PLANNERS DISCLOSURES:  Josh Fine, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Scott Webster, MD has a relevant financial affiliation. He has received an honorarium as a speaker for Astellas.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

For information please contact Rachel Waller at Rachel.Waller@BSWHealth.org